Role of Glutamatergic System and its Level of Glutamate in Rat Migraine Model

Glutamate is a major mediator of excitatory signals in the nervous system and is involved in many physiologic and pathologic processes. The understanding of glutamatergic transmission in the nervous system has been greatly expanded and the family of ionotropic and metatropic glutamate receptors. The glutamate receptors are localized at nerve terminals postsynaptic sites and glial cells and thus, they can influence and modulate the action of glutamate at different levels in the synapse. Moreover, there is substantial evidence of glial participation in glutamate nociceptive processes and neuropathic pain. Present study explains the glutamate transporters are responsible for the level of glutamate in the synaptic cleft is principally dependent on neuronal glutamate transporters in rat model.

[1]  A. Criado Recognition and Alleviation of Pain in Laboratory Animals , 2010 .

[2]  K. Messlinger Migraine: where and how does the pain originate? , 2009, Experimental Brain Research.

[3]  S. Carlton,et al.  Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion cells , 2007, The Journal of comparative neurology.

[4]  J. Mao,et al.  Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.

[5]  J. Schoenen,et al.  Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis , 2000, Neuroreport.

[6]  M. Hamon,et al.  Neurotransmitter transporters in the central nervous system. , 1999, Pharmacological reviews.

[7]  A. Doble The pharmacology and mechanism of action of riluzole , 1996, Neurology.

[8]  J. Olesen,et al.  Nitric oxide is a key molecule in migraine and other vascular headaches. , 1994, Trends in pharmacological sciences.

[9]  J. Nadler,et al.  The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. , 1993, European journal of pharmacology.

[10]  J. Korf,et al.  Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxin , 1988, Experimental Neurology.

[11]  B. Meldrum,et al.  2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I Anticonvulsant properties , 1985, Neuropharmacology.

[12]  J. Saikarthik,et al.  Histomorphometric study of neurons in the trigeminal ganglia in male wistar albino rats. , 2012 .